Key facts
- This page summarizes Paul J. Sekhri's Form 4 filing for BiomX Inc. (PHGE).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 30 Jul 2021, 09:49.
Paul J. Sekhri - 28 Jul 2021 Form 4 Insider Report for BiomX Inc. (PHGE)
- Reporting relationship
- Director
- Issuer ticker
- PHGE
- Reported as of
- 28 Jul 2021
- Net transaction value
- +$50,000
- SEC form
- 4
- Accepted by SEC
- 30 Jul 2021, 09:49:09 UTC
- Prior SEC filing
- 25 Jun 2021
- Next SEC filing
- 03 Sep 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Paul Jai Sekhri
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Paul J. Sekhri filed Form 4 for BiomX Inc. (PHGE) on 30 Jul 2021.
Change
- Previous filing in this sequence was filed on 25 Jun 2021.
- Current net transaction value: +$50,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PHGE
transaction
Common Stock
Purchase
- Transaction value
- $50,000
- Shares
- +12,500
- Change %
- Price
- $4.00
- Shares after
- 12,500
- Date
- 28 Jul 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PHGE
transaction
Derivative
Common Stock Warrant
Purchase
- Transaction value
- Shares
- +9,375
- Change %
- Price
- Shares after
- 9,375
- Date
- 28 Jul 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,375
- Exercise price
- $5.00
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The common stock and common stock warrant were acquired in the issuer's registered direct offering of units, in which each unit consisted of one share of common stock and one common stock warrant to purchase 0.75 of a share of common stock, at a price of $4.00 per unit. The price paid per unit is reflected in Table I.
Footnote F2
The common stock warrant will be exercisable six months after the date of issuance, at an exercise price of $5.00 per share and will expire five years from the date such warrant first becomes exercisable.